GB202100778D0 - Protected HDAC (Histone deacetylase) inhibitors - Google Patents
Protected HDAC (Histone deacetylase) inhibitorsInfo
- Publication number
- GB202100778D0 GB202100778D0 GBGB2100778.6A GB202100778A GB202100778D0 GB 202100778 D0 GB202100778 D0 GB 202100778D0 GB 202100778 A GB202100778 A GB 202100778A GB 202100778 D0 GB202100778 D0 GB 202100778D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- hdac
- inhibitors
- protected
- histone deacetylase
- deacetylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2100778.6A GB202100778D0 (en) | 2021-01-20 | 2021-01-20 | Protected HDAC (Histone deacetylase) inhibitors |
JP2023542741A JP2024503857A (en) | 2021-01-20 | 2022-01-20 | Protected HDAC (Histone Deacetylase) Inhibitor |
PCT/GB2022/050157 WO2022157499A1 (en) | 2021-01-20 | 2022-01-20 | Protected hdac (histone deacetylase) inhibitors |
AU2022211624A AU2022211624A1 (en) | 2021-01-20 | 2022-01-20 | Protected hdac (histone deacetylase) inhibitors |
US18/261,949 US20240123072A1 (en) | 2021-01-20 | 2022-01-20 | Protected hdac (histone deacetylase) inhibitors |
EP22702019.5A EP4281449A1 (en) | 2021-01-20 | 2022-01-20 | Protected hdac (histone deacetylase) inhibitors |
CA3204526A CA3204526A1 (en) | 2021-01-20 | 2022-01-20 | Protected hdac (histone deacetylase) inhibitors |
KR1020237028107A KR20230134547A (en) | 2021-01-20 | 2022-01-20 | Protected histone deacetylase (HDAC) inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2100778.6A GB202100778D0 (en) | 2021-01-20 | 2021-01-20 | Protected HDAC (Histone deacetylase) inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202100778D0 true GB202100778D0 (en) | 2021-03-03 |
Family
ID=74678982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2100778.6A Ceased GB202100778D0 (en) | 2021-01-20 | 2021-01-20 | Protected HDAC (Histone deacetylase) inhibitors |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202100778D0 (en) |
-
2021
- 2021-01-20 GB GBGB2100778.6A patent/GB202100778D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1220179A1 (en) | Inhibitors of histone deacetylase | |
EA201792255A1 (en) | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS FOR THEIR USE | |
EP2217588A4 (en) | Inhibitors of histone deacetylase | |
ZA200906609B (en) | Inhibitors of histone deacetylase | |
HK1142597A1 (en) | Inhibitors of histone deacetylase | |
EP1991226A4 (en) | Inhibitors of histone deacetylase | |
EP3624804A4 (en) | Histone deacetylases (hdacs) inhibitors | |
MX2020009870A (en) | Histone deacetylase inhibitors. | |
IL279940A (en) | Inhibitors of histone deacetylase | |
ZA201904459B (en) | Bicyclic inhibitors of histone deacetylase | |
EP2205070A4 (en) | N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors | |
IL279920B2 (en) | Bicyclic inhibitors of histone deacetylase | |
GB201803361D0 (en) | Histone deacetylase inhibitors | |
EP4054546A4 (en) | Selective histone deacetylase (hdac) degraders and methods of use thereof | |
MA49839A (en) | BICYCLIC HISTONE DEACETYLASE INHIBITORS | |
AU2006310257A8 (en) | Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (HDAC) inhibitors | |
EP3883572A4 (en) | Pharmaceutical composition comprising histone deacetylase 6 inhibitors | |
GB202100778D0 (en) | Protected HDAC (Histone deacetylase) inhibitors | |
GB202100776D0 (en) | Protected HDAC (Histone deacetylase) inhibitors | |
GB202009784D0 (en) | Histone deacetylase inhibitors | |
EP4074700A4 (en) | Histone deacetylase inhibitor having nitrogen-containing aromatic heterocyclic group | |
IL277582A (en) | Pharmaceutical combination products comprising a histone deacetylase (hdac) inhibitor and a tlr7 agonist and/or tlr8 agonist for the treatment of cancer | |
AU2020904810A0 (en) | Histone deacetylase inhibitors | |
GB201912813D0 (en) | Histone deacetylase inhibitors | |
GB201907955D0 (en) | Histone deacetylase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |